| US 7,576,215 B2 | ||
| Quinolines and pharmaceutical compositions thereof | ||
| Michael D. Collini, Clifton Heights, Pa. (US); Robert R. Singhaus, Jr., Pottstown, Pa. (US); Baihua Hu, Audubon, Pa. (US); James W. Jetter, Norristown, Pa. (US); Robert L. Morris, Wayne, Pa. (US); David H. Kaufman, Schwenksville, Pa. (US); Christopher P. Miller, Wayne, Pa. (US); John W. Ullrich, Exton, Pa. (US); Rayomand J. Unwalla, Eagleville, Pa. (US); Jay E. Wrobel, Lawrence, N.J. (US); Elaine Quinet, Berwyn, Pa. (US); Ponnal Nambi, Berwyn, Pa. (US); Ronald C. Bernotas, Royersford, Pa. (US); and Merle Elloso, Devon, Pa. (US) | ||
| Assigned to Wyeth, Madison, N.J. (US) | ||
| Filed on Dec. 10, 2004, as Appl. No. 11/10,236. | ||
| Claims priority of provisional application 60/529009, filed on Dec. 12, 2003. | ||
| Claims priority of provisional application 60/600296, filed on Aug. 10, 2004. | ||
| Prior Publication US 2005/0131014 A1, Jun. 16, 2005 | ||
| Int. Cl. C07D 215/38 (2006.01) | ||
| U.S. Cl. 546—156 [546/153; 546/157; 546/167] | 9 Claims |
1. A compound of formula I having the structure:
![]() wherein:
R1 is —H;
X1 is a bond, C1 to C5 alkyl, —C(O)—, —C(═CR8R9)—, —O—, —S(O)t—, —NR8—, —CR8R9—, —CHR23, —CR8(CR9)—, —C(CR8)2—, —CR8(OC(O)R9)—, —C═NOR9—, —C(O)NR8—, —CH2O—, —CH2S—, —CH2NR8—, —OCH2—, —SCH2—, —NR8CH2—, or
![]() R2 is H, C1 to C6 alkyl, C2 to C6 alkenyl, C2 to C6 alkynyl, C3 to C6 cycloalkyl, —CH2OH, C7 to C11 arylalkyl, phenyl, naphthyl, C1 to C3 perfluoroalkyl, CN, C(O)NH2, CO2R12 or phenyl substituted independently by one or more of the groups independently selected from C1 to C3 alkyl, C2 to C4 alkenyl, C2 to C4 alkynyl, C1 to C3 alkoxy, C1 to C3 perfluoroalkyl, halogen, —NO2, —NR8R9, —CN, —OH, and C1 to C3 alkyl substituted with 1 to 5 fluorines, or
R2 is a heterocycle selected from the group consisting of pyridine, thiophene, benzisoxazole, benzothiophene, oxadiazole, pyrrole,
pyrazole, imidazole and furan, each of which may be optionally substituted with one to three groups independently selected
from C1 to C3 alkyl, C1 to C3 alkoxy, C1 to C3 perfluoroalkyl, halogen, —NO2, —NR8R9, —CN, and C1 to C3 alkyl substituted with 1 to 5 fluorines;
X2 is a bond or —CH2—;
R3 is phenyl, naphthyl, or phenyl or naphthyl substituted independently by one to four groups independently selected from C1 to C3 alkyl, hydroxy, phenyl, acyl, halogen, —NH2, —CN, —NO2, C1 to C3 alkoxy, C1 to C3 perfluoroalkyl, C1 to C3 alkyl substituted with 1 to 5 fluorines, NR14R15, —C(O)R10, —C(O)NR10R11, —C(O)NR11A, —C≡CR8, —CH═CHR8, —WA, —C≡CA, —CH═CHA, —WYA, —WYNR11-A, —WYR10, —WY(CH2)jA, —WCHR11(CH2)jA, —W(CH2)jA, —W(CH2)jR10, —CHR11W(CH2)jR10, —CHR11W(CH2)jA, —CHR11NR12YA, —CHR11NR12YR10, pyrrole, —W(CH2)jA(CH2)kD(CH2)pZ, —W(CR18R19)A(CH2)kD(CH2)pZ, —(CH2)jWA(CH2)kD(CH2)pZ, —CH═CHA(CH2)kD(CH2)pZ, —C≡CA(CH2)kD(CH2)pZ, —W(CH2)jC≡CA(CH2)kD(CH2)pZ, and —W(CH2)jZ, or
R3 is a heterocycle selected from pyrimidine, thiophene, furan, benzothiophene, indole, benzofuran, benzimidazole, benzothiazole,
benzoxazole, and quinoline, each of which may be optionally substituted with one to three groups independently selected from
C1 to C3 alkyl, C1 to C3 alkoxy, hydroxy, phenyl, acyl, halogen, —NH2, —CN, —NO2, C1 to C3 perfluoroalkyl, C1 to C3 alkyl substituted with 1 to 5 fluorines, —C(O)R10, —C(O)NR10R11, —C(O)NR11A, —C≡CR8, —CH═CHR8, —WA, —C≡CA, —CH═CHA, —WYA, —WYR10, —WY(CH2)jA, —W(CH2)jA, —W(CH2)jR10, —CHR11W(CH2)jR10, —CHR11W(CH2)jA, —CHR11NR12YA, —CHR11NR12YR10, —WCHR11(CH2)jA, —W(CH2)jA(CH2)kD(CH2)pZ, —W(CR18R19)A(CH2)kD(CH2)pZ, —(CH2)jWA(CH2)kD(CH2)pZ, —CH═CHA(CH2)kD(CH2)pZ, —C≡CA(CH2)kD(CH2)pZ, —W(CH2)jC≡CA(CH2)kD(CH2)pZ, and —W(CH2)jZ;
W is a bond, —O—, —S—, —S(O)—, —S(O)2—, —NR11—, or —N(COR12)—;
Y is —CO—, —S(O)2—, —CONR13, —CONR13CO—, —CONR13SO2—, —C(NCN)—, —CSNR13, —C(NH)NR13, or —C(O)O—;
j is 0 to 3;
k is 0 to 3;
t is 0 to 2;
D is a bond, —CH═CH—, —C≡C—, —C═, —C(O)—, phenyl, —O—, —NH—, —S—, —CHR14—, —CR14R15—, —OCHR14, —OCR14R15—, or —CH(OH)CH(OH)—;
p is 0 to 3;
Z is —CO2R11, —CONR10R11, —C(NR10)NR11R12, —CONH2NH2, —CN, —CH2OH, —NR16R17, phenyl, CONHCH(R20)COR12, phthalimide, pyrrolidine-2,5-dione, thiazolidine-2,4-dione, tetrazolyl, pyrrole, indole, oxazole, 2-thioxo-1,3-thiazolinin-4-one,
C1 to C7 amines, C3 to C7 cyclic amines, or C1 to C3 alkyl substituted with one to two OH groups; wherein said pyrrole is optionally substituted with one or two substituents independently
selected from the group consisting of —CO2CH3, —CO2H, —COCH3, —CONH2 and —CN; wherein said C1 to C7 amines are optionally substituted with one to two substituents independently selected from the group consisting of —OH, halogen,
—OCH3, and —C≡CH; wherein said phenyl is optionally substituted with CO2R11, and wherein said C3 to C7 cyclic amines are optionally substituted with one or two substituents independently selected from the group consisting of
—OH —CH2OH, C1 to C3 alkyl, —CH2OCH3, —CO2CH3, and —CONH2, and wherein said oxazole is optionally substituted with CH2CO2R11;
A is phenyl, naphthyl, tetrahydronaphthyl, indan or biphenyl, each of which may be optionally substituted by one to four groups
independently selected from halogen, C1 to C3 alkyl, C2 to C4 alkenyl, C2 to C4 alkynyl, acyl, hydroxy, halogen, —CN, —NO2, —CO2R11, —CH2CO2R11, phenyl, C1 to C3 perfluoroalkoxy, C1 to C3 perfluoroalkyl, —NR10R11, —CH2NR10R11, —SR11, C1 to C6 alkyl substituted with 1 to 5 fluorines, C1 to C3 alkyl substituted with 1 to 2 —OH groups, C1 to C6 alkoxy optionally substituted with 1 to 5 fluorines, or phenoxy optionally substituted with 1 to 2 CF3 groups; or
A is a heterocycle selected from pyrrole, pyridine, pyridine-N-oxide, pyrimidine, pyrazole, thiophene, furan, quinoline, oxazole,
thiazole, imidazole, isoxazole, indole, benzo[1,3]-dioxole, benzo[1,2,5]-oxadiazole, isochromen-1-one, benzothiophene, benzofuran,
2,3-dihydrobenzo[1,4]-dioxine, bitheinyl, quinazolin-2,4-91,3H]dione, and 3-H—isobenzofuran-1-one, each of which may be optionally
substituted by one to three groups independently selected from halogen, C1 to C3 alkyl, acyl, hydroxy, —CN, —NO2, C1 to C3 perfluoroalkyl, —NR10R11, —CH2NR10R11, —SR11, C1 to C3 alkyl substituted with 1 to 5 fluorines, and C1 to C3 alkoxy optionally substituted with 1 to 5 fluorines;
R4, R5, and R6 are each, independently, —H or —F;
R7 is C1 to C4 alkyl, C1 to C4 perfluoroalkyl, halogen, —NO2, —CN, phenyl or phenyl substituted with one or two groups independently selected from halogen, C1 to C2 alkyl and OH;
provided that if X1R2 forms hydrogen, then R3 is selected from:
(a) phenyl substituted by —W(CH2)jA(CH2)kD(CH2)pZ, —W(CR18R19)A(CH2)kD(CH2)pZ, —(CH2)jWA(CH2)kD(CH2)pZ, —CH═CHA(CH2)kD(CH2)pZ, —C≡CA(CH2)kD(CH2)pZ, or —W(CH2)jC≡CA(CH2)kD(CH2)pZ, wherein the phenyl moiety is further optionally substituted with one or two groups independently selected from C1 to C2 alkyl, C1 to C2 perfluoroalkyl, halogen, and CN; and
(b) a heterocycle selected from pyrimidine, thiophene, and furan, each of which is substituted by one of —W(CH2)jA(CH2)kD(CH2)pZ, —W(CR18R19)A(CH2)kD(CH2)pZ, —(CH2)jWA(CH2)kD(CH2)pZ, —CH═CHA(CH2)kD(CH2)pZ, —C≡CA(CH2)kD(CH2)pZ, or —W(CH2)jC≡CA(CH2)kD(CH2)pZ;
each R8 is independently —H, or C1 to C3 alkyl;
each R9 is independently —H, or C1 to C3 alkyl;
each R10 is independently —H, —CH, C1 to C3 alkoxy, C1 to C7 alkyl, C3 to C7 alkenyl, C3 to C7 alkynyl, C3 to C7 cycloalkyl, —CH2CH2OCH3, 2-methyl-tetrahydro-furan, 2-methyl-tetrahydro-pyran, 4-methyl-piperidine, morpholine, pyrrolidine, or phenyl optionally
substituted with one or two C1 to C3 alkoxy groups, wherein said C1 to C7 alkyl is optionally substituted with 1, 2 or 3 groups independently selected from C1 to C3 alkoxy, C1 to C3 thioalkoxy and CN;
each R11 is independently —H, C1 to C3 alkyl or R22;
or R10 and R11, when attached to the same atom, together with said atom form:
a 5 to 7 membered saturated ring, optionally substituted by 1 to 2 groups independently selected from C1 to C3 alkyl, OH and C1—C3 alkoxy; or
a 5 to 7 membered ring containing 1 or 2 heteroatoms, optionally substituted by 1 to 2 groups independently selected from
C1 to C3 alkyl, OH and C1—C3 alkoxy;
each R12 is independently —H, or C1 to C3 alkyl;
each R13 is independently —H, or C1 to C3 alkyl;
each R14 and R15 is, independently, C1 to C7 alkyl, C3 to C8 cycloalkyl, C2 to C7 alkenyl, C2 to C7 alkynyl, —CH, —F, C7 to C14 arylalkyl, where said arylalkyl is optionally substituted with 1 to 3 groups independently selected from NO2, C1 to C6 alkyl, C1 to C3 perhaloalkyl, halogen, CH2CO2R11, phenyl and C1 to C3 alkoxy, or R14 and R15 together with the atom to which they are attached can form a 3 to 7 membered saturated ring;
each R16 and R17 is, independently, hydrogen, C1 to C3 alkyl, C1 to C3 alkenyl, C1 to C3 alkynyl, phenyl, benzyl or C3 to C8 cycloalkyl, wherein said C1 to C3 alkyl is optionally substituted with one OH group, and wherein said benzyl is optionally substituted with 1 to 3 groups selected
from C1 to C3 alkyl and C1 to C3 alkoxy; or
R16 and R17, together with the atom to which they are attached, can form a 3 to 8 membered heterocycle which is optionally substituted
with one or two substituents independently selected from the group consisting of C1 to C3 alkyl, —OH, CH2OH, —CH2OCH3, —CO2CH3, and —CONH2;
each R18 and R19 is, independently, C1 to C3 alkyl;
each R20 is independently H, phenyl, or the side chain of a naturally occurring alpha amino acid;
each R22 is independently arylalkyl optionally substituted with CH2COOH; and
each R23 is phenyl;
or a pharmaceutically acceptable salt thereof.
|